![](https://healthtipsgalaxy.com/wp-content/uploads/2022/09/fda-approves-spevigo-f-348x215.jpg)
FDA approves SPEVIGO for generalized pustular psoriasis flares
The U.S. Food and Drug Administration has approved SPEVIGO (spesolimab-sbzo) as the first treatment option for generalized pustular psoriasis (GPP) flares in adults. SPEVIGO is a novel, selective antibody infusion …
FDA approves SPEVIGO for generalized pustular psoriasis flares Read More